References
- Sibai B. M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing ? Am J Obstet Gynecol, 1990, 162: 311–16.
- Baxter J. K., Weinstein L. HELLP syndrome: The State of the Art. Obstet Gynecol Surv, 2004, 59: 838–45.
- Jacobson L. E., Kirton O. C., Gomez G. A. The use of an absorbable mesh wrap in the management of major liver injuries. Surgery, 1992, 111: 455–61.
- Wicke C., Pereira P. L., Neeser E., Flesch I., Rodegerdts E. A., Becker H. D. Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic options. A unicenter study. Am J Obstet Gynecol, 2004, 190: 106–12.
- Merchant S. H., Mathew P., Vanderjagt T. J., Howdieshell T. R., Crookston K. P. Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol, 2004, 103: 1055–8.
- Dart B. W., Cockerham W. T., Torres C., Kipikasa J. H., Maxwell R. A. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma, 2004, 57: 171–4.
- Hedner U., Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion, 2002, 42: 114–24.
- Moscardo F., Perez F., de la R. J., Balerdi B. et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol, 2001, 114: 174–6.